Background Little is known about the role of interleukin (IL) in patients with acute myocardial
infarction (MI), especially soluble IL-2 receptor (sIL-2R) and IL-8. We aim to evaluate, in MI …

Background Acute kidney injury (AKI) is the most common and critical complication in
patients with acute myocardial infarction (AMI). This study aims to evaluate the significance …

Background: The role of soluble interleukin-1 receptor type 2 (sIL-1R2) in acute myocardial
infarction (AMI) remains undocumented. In the present study, we aimed to evaluate the …

A comment on this article appears in" Response to: Soluble regulators of Interleukin-1
signaling: Novel biomarkers for early acute myocardial infarction diagnosis and to predict …

Aims Little is known about the clinical relevance of interleukin (IL)-6 in patients with acute ST-
elevation myocardial infarction (STEMI). This study examined the possible associations of …

Abstract Background The interleukin-6 (IL-6) pathway has a crucial role in the pathogenesis
of atherosclerosis, the main cause of cardiovascular diseases. We aimed to characterize the …

Biomarkers such as interleukin-6 (IL-6), soluble interleukin-6 receptor (sIL-6R), and high
sensitive C-reactive protein (hsCRP) have been reported to be elevated in acute myocardial …

Several lines of evidence indicate that increased inflammatory cytokine levels can be used
for risk prediction in patients with acute coronary syndrome (ACS). This study therefore …

Background and aims Myocardial infarction triggers an inflammatory response involved in
cardiac repair. We studied the association of the interleukin 6 (IL-6) cascade with infarct size …

Objective Conflicting results have been reported on the association between blood level of
interleukin-6 and adverse outcomes in patients with acute coronary syndrome (ACS). The …